{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T22:11:32Z","timestamp":1772316692738,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.contraception.2005.06.057","type":"journal-article","created":{"date-parts":[[2005,11,17]],"date-time":"2005-11-17T07:16:37Z","timestamp":1132211797000},"page":"30-33","source":"Crossref","is-referenced-by-count":20,"title":["Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 \u03bcg and ethinylestradiol 15 \u03bcg (Minesse\u00ae)"],"prefix":"10.1016","volume":"73","author":[{"given":"Ione C.","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Isaia","family":"Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Dirceu","family":"Faggion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmund Chada","family":"Baracat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.06.057_bib1","first-page":"1034","article-title":"Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins","volume":"81","author":"Speroff","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.06.057_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(94)90106-6","article-title":"New progestogens in oral contraception","volume":"49","author":"Fotherby","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.057_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2165\/00003495-199550020-00010","article-title":"Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations","volume":"50","author":"Wilde","year":"1995","journal-title":"Drugs"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2005.06.057_bib4","first-page":"17","article-title":"Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 microg\/ethinylestradiol 15 microg and a 21-day regimen of desogestrel 150 microg\/ethinylestradiol 20 microg","volume":"4","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2005.06.057_bib5","first-page":"9","article-title":"The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg","volume":"4","year":"1999","journal-title":"Eur J Contracep Reprod Health Care"},{"issue":"2","key":"10.1016\/j.contraception.2005.06.057_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00003081-198706000-00017","article-title":"The epidemiology and social impact of premenstrual symptoms","volume":"30","author":"Johnson","year":"1987","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.06.057_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.med.48.1.447","article-title":"Premenstrual syndromes","volume":"48","author":"Steiner","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.contraception.2005.06.057_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.contraception.2003.12.017","article-title":"Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol","volume":"69","author":"Winkler","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.057_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1471-0528.1995.tb11396.x","article-title":"The combined oral contraceptive pill: what advice should we give when tablets are missed?","volume":"102","author":"Korver","year":"1995","journal-title":"Br Obstet Gynaecol"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2005.06.057_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/13625189909085264","article-title":"An open-label study of the effects of a 24-day regimen of gestodene 60 microg\/ ethinylestradiol 15 microg on endometrial histological findings in healthy women","volume":"4","author":"Oosterbaan","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.06.057_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00016349109007167","article-title":"Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol","volume":"70","author":"Lammers","year":"1991","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2005.06.057_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","article-title":"Effect of a 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity","volume":"72","author":"Sullivan","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2005.06.057_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/09513599609041268","article-title":"A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene","volume":"10","author":"Dursterberg","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2005.06.057_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0010-7824(01)00213-X","article-title":"A 12-month clinical investigation with a 24-day regimen containing 15 microg ethinylestradiol plus 60 microg gestodene with respect to hemostasis and cycle control","volume":"63","author":"Fruzzetti","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.057_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/bmj.312.7023.88","article-title":"Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women","volume":"312","author":"Lewis","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2005.06.057_bib16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.315.7109.679b","article-title":"Lowered risk of dying of heart attack with third generation pill may offset risk of dying of thromboembolism","volume":"315","author":"Lewis","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2005.06.057_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1783\/147118903101197188","article-title":"Newer progestogens","volume":"29","author":"Rowlands","year":"2003","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.06.057_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/01674820309039670","article-title":"Factor structure of the modified Moos Menstrual Distress Questionnaire: assessment of prospectively reported follicular, menstrual and premenstrual symptomatology","volume":"24","author":"Ross","year":"2003","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2005.06.057_bib19","first-page":"79","article-title":"Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life","volume":"48","author":"Borenstein","year":"2003","journal-title":"J Reprod Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405002544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405002544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T18:54:22Z","timestamp":1548010462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782405002544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0010782405002544"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.06.057","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}